Definium Therapeutics (DFTX) Other Non Operating Income (2021 - 2026)
Definium Therapeutics' Other Non Operating Income was $86.23 million in Q2 2026, compared with $2.23 million a year earlier and up 330.2% from the prior quarter.
Powered by 
Analysis
Definium Therapeutics (DFTX) Other Non Operating Income (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Definium Therapeutics' Other Non Operating Income was $133.88 million through Jun 30, 2026, up 395.8% year-over-year; for FY2025, it was $22.83 million, up 43.2% from FY2024.
- In earlier years, Other Non Operating Income was $15.94 million in FY2024 (+140.2%), $6.64 million in FY2023 (-30.4%), $9.54 million in FY2022 and -$339,000 in FY2021.
- The Q2 2026 figure marks the highest quarterly Other Non Operating Income in data going back to Q1 2021.
- Compared with a year earlier, Other Non Operating Income was higher in five of the last seven quarters, with growth averaging 48.3%.
- The best year-over-year quarter for Other Non Operating Income over five years was Q3 2023 (growth of 641.6%); the worst was Q2 2025 (a decline of 88.0%).
- Per Business Quant data, DFTX's Other Non Operating Income in the three quarters before Q2 2026 was $20.05 million (Q1 2026), $5.06 million (Q4 2025) and $22.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Definium Therapeutics | 4.00 Bn | 4.00 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.23 Mn |
| Mar 31, 2026 | 20.05 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 22.55 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 8.81 Mn |
| Dec 31, 2024 | 4.85 Mn |
| Sep 30, 2024 | 11.11 Mn |
| Jun 30, 2024 | 18.60 Mn |
| Mar 31, 2024 | 32.89 Mn |
| Dec 31, 2023 | 2.97 Mn |
| Sep 30, 2023 | 3.69 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Sep 30, 2022 | 498,000.00 |
| Jun 30, 2022 | -89,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2021 | -433,000.00 |
| Sep 30, 2021 | -40,000.00 |
API Access
Definium Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=DFTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();